Pacira | PCRX - Créances Commerciales





Créances Commerciales Changement Date
Astellas Pharma JPY 844.8B 83.04B 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Cara Therapeutics USD 2.24M 2.26M 2025-03
Coherus Biosciences USD 18.42M 232.08M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
J&J USD 22.54B 1.21B 2026-03
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Novo Nordisk DKK 114.94B 8.68B 2026-06
Omeros USD 8.08M 440K 2024-06
Pacira USD 132.42M 6.78M 2026-06
Perrigo USD 697.1M 84.3M 2026-03
Pfizer USD 16.19B 19M 2026-06
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
Teva Pharmaceutical Industries USD 3.49B 100M 2026-06
Xeris Pharmaceuticals USD 56.29M 5.24M 2026-03
Zoetis USD 1.57B 65M 2026-06